| Glaxosmithkline Pharmaceuticals Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
|
|
|
|
|
|
|
|
| Year | High (₹) | Low (₹) | Close (₹) | P/E High | P/E Low | P/E Close | Mkt Cap (₹ In Cr) |
|---|---|---|---|---|---|---|---|
| Jun 2024 | 2,759.00 | 2,239.35 | 2,652.30 | 74.32 | 55.19 | 68.99 | 44,931.56 |
| May 2024 | 2,652.15 | 1,965.00 | 2,630.60 | 69.55 | 50.91 | 68.43 | 44,563.95 |
| Apr 2024 | 2,163.60 | 1,825.05 | 2,087.10 | 57.66 | 45.53 | 54.29 | 35,356.73 |
| Mar 2024 | 2,199.65 | 1,872.15 | 1,943.10 | 58.62 | 48.45 | 50.54 | 32,917.29 |
| Feb 2024 | 2,649.95 | 2,094.15 | 2,172.10 | 85.21 | 58.24 | 62.72 | 36,796.68 |
| Jan 2024 | 2,375.00 | 1,907.35 | 2,247.90 | 69.90 | 53.80 | 64.91 | 38,080.78 |
| Dec 2023 | 1,958.55 | 1,664.75 | 1,897.40 | 58.37 | 47.76 | 54.79 | 32,143.10 |
| Nov 2023 | 1,725.00 | 1,387.90 | 1,655.90 | 50.74 | 39.95 | 47.81 | 28,051.95 |
| Oct 2023 | 1,598.45 | 1,418.30 | 1,423.15 | 47.92 | 40.81 | 41.09 | 24,109.02 |
| Sep 2023 | 1,622.95 | 1,420.00 | 1,544.50 | 47.81 | 40.48 | 44.60 | 26,164.76 |